Guru Ownership Trend
Guru Analysis for Capricor Therapeutics, Inc. (CAPR)
Capricor Therapeutics, Inc. (CAPR), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $2.04 M.
Top institutional holders include Jefferies Group and Steven Cohen.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $17.1 M net outflow during the quarter.
Recent activity highlights Paul Tudor Jones who opened a new position. Conversely, Steven Cohen reduced exposure by 88.5%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Capricor Therapeutics, Inc. (CAPR)
Major holders include Jefferies Group ($2.55 M), Steven Cohen ($2.28 M), Paul Tudor Jones ($380,849). According to the latest reported data, 4 tracked investment managers collectively hold approximately 225,242 shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $17.1 M, with 2 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 2 managers trimmed their positions, while 0 fully exited CAPR. The total reported sell value was $17.52 M.
Yes, 1 managers opened new positions in CAPR, and 1 increased their existing holdings. The total reported buy value was $414,416.51.